← Open Payments lookup

KIRSTEN SCHMITT: Open Payments

NPI 1528121811 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,758 in 131 payments from 20 companies in 2025. Trend: 2023 $2,319 · 2024 $2,157 · 2025 $2,758

Food & beverage: $2,758
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP26$537
GlaxoSmithKline, LLC.22$359
Novartis Pharmaceuticals Corporation11$296
Amgen Inc.11$220
GENZYME CORPORATION8$192
Takeda Pharmaceuticals U.S.A., Inc.12$177
CSL Behring7$160
ARS Pharmaceuticals Operations, Inc.6$127
Genentech USA, Inc.4$120
Regeneron Healthcare Solutions, Inc.4$113

Products named: TEZSPIRE, DUPIXENT, NUCALA, AIRSUPRA, Xolair, NEFFY, Rhapsido, VTAMA.

Industry payments across MI — which companies pay providers there.